Kiniksa Pharmaceuticals International, plc Debt Securities, Available-for-sale
Kiniksa Pharmaceuticals International, plc (KNSA) had Debt Securities, Available-for-sale of $292.57 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-04-28
- 2026-03-31: Debt Securities, Available-for-sale $292.57M.
- 2025-12-31: Debt Securities, Available-for-sale $248.48M.
- 2025-09-30: Debt Securities, Available-for-sale $254.56M.
- 2025-06-30: Debt Securities, Available-for-sale $115.75M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2026-03-31 | $292.57M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $248.48M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $254.56M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $115.75M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $141.05M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $60.05M 10-K · filed 2026-02-24 |
| 2024-09-30 | $126.40M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $136.41M 10-Q · filed 2024-07-25 |
| 2023-12-31 | $100.41M 10-Q · filed 2024-10-29 |